Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
| ▸ | CASP7 | P55210 | 1/20 | 0.34 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
| ▸ | CFTR | P13569 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31346072 | 0.80 | FFAR1 (0.40) | FFAR1TEAD1CYP19A1ARHTR1A | |
| SCHEMBL31346059 | 0.78 | FFAR1 (0.38) | FFAR1CYP19A1HTR1A | |
| SCHEMBL31346041 | 0.78 | FFAR1 (0.38) | FFAR1CYP19A1HTR1A | |
| SCHEMBL31345962 | 0.77 | KDM1A (0.40) | FFAR1TEAD1CASP3CASP7CASP8 | |
| SCHEMBL31345981 | 0.77 | KDM1A (0.40) | FFAR1TEAD1CASP3CASP7CASP8 | |
| SCHEMBL31345965 | 0.75 | FFAR1 (0.37) | FFAR1TEAD1CYP19A1CASP3CASP7 | |
| SCHEMBL31346068 | 0.75 | MRGPRX4 (0.45) | FFAR1TEAD1CASP3CASP7CASP8 | |
| SCHEMBL31345963 | 0.75 | TEAD1 (0.42) | FFAR1TEAD1CYP19A1ARHTR1A | |
| SCHEMBL31346002 | 0.75 | TEAD1 (0.42) | FFAR1TEAD1CYP19A1ARHTR1A | |
| SCHEMBL31345978 | 0.73 | CFTR (0.49) | FFAR1ARCFTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712967-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | Enveda Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024239000-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | ENVEDA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |